ReferIndia News Clark to acquire Tylenol maker Kenvue in $48.7 billion cash and stock deal; $1.9 billion cost savings targeted post

ReferIndia News

ePrescribe

Upgrade your clinic to smart, simple, and paperless management—start today!

Know more
News Image

Clark to acquire Tylenol maker Kenvue in $48.7 billion cash and stock deal; $1.9 billion cost savings targeted post

Published on: Nov. 3, 2025, 6:57 p.m. | Source: Times of India

International Business News: Kimberly-Clark is acquiring Tylenol maker Kenvue for approximately $48.7 billion in a cash-and-stock deal, creating a major consumer health goods comp

Checkout more news
Ad Banner

Growth Housing by HoABL

100% buy back of if you feel home is not right for you for the same price which you paid.

Book Now
ReferIndia News contact